LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers

Salivary gland cancers (SGCs) are rare yet aggressive malignancies with significant histological heterogeneity, which has made prediction of prognosis and development of targeted therapies challenging. In majority of patients, local recurrence and/or distant metastasis are common and systemic treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lulla, Amriti R., Akli, Said, Karakas, Cansu, Ha, Min Jin, Fowlkes, Natalie W., Mitani, Yoshitsugu, Bui, Tuyen, Wang, Jing, Rao, Xiayu, Hunt, Kelly K., Meijer, Laurent, El-Naggar, Adel K., Keyomarsi, Khandan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121779/
https://www.ncbi.nlm.nih.gov/pubmed/33990543
http://dx.doi.org/10.1038/s41389-021-00324-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121779/
https://www.ncbi.nlm.nih.gov/pubmed/33990543
http://dx.doi.org/10.1038/s41389-021-00324-z

Ejemplares similares